Skip to main content
Erschienen in: Supportive Care in Cancer 8/2019

11.12.2018 | Original Article

Evaluation of the adherence of distress screening with the distress thermometer in cancer patients 4 years after implementation

verfasst von: Anna Götz, A. Kröner, J. Jenewein, R. Spirig

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Identifying and assessing psychosocial distress with an appropriate screening instrument is essential when caring for cancer patients. Since 2012, the distress thermometer (DT) has been used by nurses for all cancer inpatients at the Comprehensive Cancer Center Zurich. We wanted to identify nurses’ adherence to the screening protocol, differences between screened and not screened patients and the relationship between screening rate and productivity.

Methods

This retrospective descriptive study used screening and referral data as well as socioeconomic and disease-related data of inpatients at the Comprehensive Cancer Center Zurich. This was collected from the electronic patient documentation system. Additionally, data showing the productivity of all wards was used. All data were analyzed descriptive.

Results

Since 2012, 40.6% (4541) of the 11,184 patients have been screened. The screening rate was initially significantly lower but settled at 40% after 2 years. There was a higher screening rate among Swiss, married, male, and emergency patients and patients with hematology diseases, brain tumors, or head and neck cancer (p < 0.001). Every fourth patient with a moderate to severe distress level requested referral to a psychosocial service. Significantly more screened patients were referred to the social service (44.7%) than to the psycho-oncology service (9.4%). Only 22.9% of all referrals were made on the day of screening or a day later. There were only two wards of 15 with a significant relationship between productivity and screening rate.

Conclusions

Screening is useful in recognizing distress among patients, but screening practice needs to be reconsidered.
Literatur
1.
Zurück zum Zitat Holland JC, Andersen B, Breitbart WS, Compas B, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF, Hoofring L, Jacobsen PB, Knight SJ, Learson K, Levy MH, Loscalzo MJ, Manne S, McAllister-Black R, Riba MB, Roper K, Valentine AD, Wagner LI, Zevon MA, NCCN Distress Management Panel (2010) Distress management. J Natl Compr Cancer Netw 8(4):448–485CrossRef Holland JC, Andersen B, Breitbart WS, Compas B, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF, Hoofring L, Jacobsen PB, Knight SJ, Learson K, Levy MH, Loscalzo MJ, Manne S, McAllister-Black R, Riba MB, Roper K, Valentine AD, Wagner LI, Zevon MA, NCCN Distress Management Panel (2010) Distress management. J Natl Compr Cancer Netw 8(4):448–485CrossRef
2.
Zurück zum Zitat Feldstain A, Tomei C, Bélanger M, Lebel S (2014) Screening for distress in patients with cancer: methodologic considerations. Curr Oncol 21(2):e330–e333CrossRefPubMedPubMedCentral Feldstain A, Tomei C, Bélanger M, Lebel S (2014) Screening for distress in patients with cancer: methodologic considerations. Curr Oncol 21(2):e330–e333CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Mehnert A et al (2006) Assessment of psychosocial distress and resources in oncology--a literature review about screening measures and current developments. Psychother Psychosom Med Psychol 56(12):462–479CrossRefPubMed Mehnert A et al (2006) Assessment of psychosocial distress and resources in oncology--a literature review about screening measures and current developments. Psychother Psychosom Med Psychol 56(12):462–479CrossRefPubMed
4.
Zurück zum Zitat NCCN, NCCN clinical practice guidelines in oncology, in Distress management. 2016: NCCN.org NCCN, NCCN clinical practice guidelines in oncology, in Distress management. 2016: NCCN.​org
5.
Zurück zum Zitat Götz A, Kröner A, Staudacher D, Spirig R (2017) Einführung des Belastungsthermometers auf einer onkologischen Station. Pflege 30(5):289–297CrossRefPubMed Götz A, Kröner A, Staudacher D, Spirig R (2017) Einführung des Belastungsthermometers auf einer onkologischen Station. Pflege 30(5):289–297CrossRefPubMed
6.
Zurück zum Zitat McCarter K, Britton B, Baker AL, Halpin SA, Beck AK, Carter G, Wratten C, Bauer J, Forbes E, Booth D, Wolfenden L (2018) Interventions to improve screening and appropriate referral of patients with cancer for psychosocial distress: systematic review. BMJ Open 8(1):e017959CrossRefPubMedPubMedCentral McCarter K, Britton B, Baker AL, Halpin SA, Beck AK, Carter G, Wratten C, Bauer J, Forbes E, Booth D, Wolfenden L (2018) Interventions to improve screening and appropriate referral of patients with cancer for psychosocial distress: systematic review. BMJ Open 8(1):e017959CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Mitchell AJ (2013) Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol 52(2):216–224CrossRefPubMed Mitchell AJ (2013) Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol 52(2):216–224CrossRefPubMed
8.
Zurück zum Zitat Tondorf T, Grossert A, Rothschild SI, Koller MT, Rochlitz C, Kiss A, Schaefert R, Meinlschmidt G, Hunziker S, Zwahlen D (2018) Focusing on cancer patients’ intentions to use psychooncological support: a longitudinal, mixed-methods study. Psychooncology 27(6):1656–1663CrossRefPubMedPubMedCentral Tondorf T, Grossert A, Rothschild SI, Koller MT, Rochlitz C, Kiss A, Schaefert R, Meinlschmidt G, Hunziker S, Zwahlen D (2018) Focusing on cancer patients’ intentions to use psychooncological support: a longitudinal, mixed-methods study. Psychooncology 27(6):1656–1663CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Zebrack B, Kayser K, Bybee D, Padgett L, Sundstrom L, Jobin C, Oktay J (2017) A practice-based evaluation of distress screening protocol adherence and medical service utilization. J Natl Compr Cancer Netw 15(7):903–912CrossRef Zebrack B, Kayser K, Bybee D, Padgett L, Sundstrom L, Jobin C, Oktay J (2017) A practice-based evaluation of distress screening protocol adherence and medical service utilization. J Natl Compr Cancer Netw 15(7):903–912CrossRef
10.
Zurück zum Zitat Carlson LE, Waller A, Mitchell AJ (2012) Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 30(11):1160–1177CrossRef Carlson LE, Waller A, Mitchell AJ (2012) Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 30(11):1160–1177CrossRef
11.
Zurück zum Zitat Fulcher CD, Gosselin-Acomb TK (2007) Distress assessment: practice change through guideline implementation. Clin J Oncol Nurs 11(6):817–821CrossRefPubMed Fulcher CD, Gosselin-Acomb TK (2007) Distress assessment: practice change through guideline implementation. Clin J Oncol Nurs 11(6):817–821CrossRefPubMed
12.
Zurück zum Zitat Hahn C, Joo SH, Chae JH, Lee CU, Kim TS (2017) Feasibility of psychosocial distress screening and management program for hospitalized cancer patients. Psychiatry Investig 14(6):734–745CrossRefPubMedPubMedCentral Hahn C, Joo SH, Chae JH, Lee CU, Kim TS (2017) Feasibility of psychosocial distress screening and management program for hospitalized cancer patients. Psychiatry Investig 14(6):734–745CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Zebrack B, Kayser K, Sundstrom L, Savas SA, Henrickson C, Acquati C, Tamas RL (2015) Psychosocial distress screening implementation in cancer care: an analysis of adherence, responsiveness, and acceptability. J Clin Oncol 33(10):1165–1170CrossRefPubMed Zebrack B, Kayser K, Sundstrom L, Savas SA, Henrickson C, Acquati C, Tamas RL (2015) Psychosocial distress screening implementation in cancer care: an analysis of adherence, responsiveness, and acceptability. J Clin Oncol 33(10):1165–1170CrossRefPubMed
14.
Zurück zum Zitat Chiang AC, Buia Amport S, Corjulo D, Harvey KL, McCorkle R (2015) Incorporating patient-reported outcomes to improve emotional distress screening and assessment in an ambulatory oncology clinic. J Oncol Pract 11(3):219–222CrossRefPubMed Chiang AC, Buia Amport S, Corjulo D, Harvey KL, McCorkle R (2015) Incorporating patient-reported outcomes to improve emotional distress screening and assessment in an ambulatory oncology clinic. J Oncol Pract 11(3):219–222CrossRefPubMed
15.
Zurück zum Zitat Pretto M, Spirig R, Milisen K, DeGeest S, Regazzoni P, Hasemann W (2009) Effects of an interdisciplinary nurse-led Delirium Prevention and Management Program (DPMP) on nursing workload: a pilot study. Int J Nurs Stud 46(6):804–812CrossRefPubMed Pretto M, Spirig R, Milisen K, DeGeest S, Regazzoni P, Hasemann W (2009) Effects of an interdisciplinary nurse-led Delirium Prevention and Management Program (DPMP) on nursing workload: a pilot study. Int J Nurs Stud 46(6):804–812CrossRefPubMed
16.
Zurück zum Zitat Mitchell AJ, Lord K, Slattery J, Grainger L, Symonds P (2012) How feasible is implementation of distress screening by cancer clinicians in routine clinical care? Cancer 118(24):6260–6269CrossRefPubMed Mitchell AJ, Lord K, Slattery J, Grainger L, Symonds P (2012) How feasible is implementation of distress screening by cancer clinicians in routine clinical care? Cancer 118(24):6260–6269CrossRefPubMed
17.
Zurück zum Zitat Mitchell AJ, Vahabzadeh A, Magruder K (2011) Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research. Psychooncology 20(6):572–584CrossRefPubMed Mitchell AJ, Vahabzadeh A, Magruder K (2011) Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research. Psychooncology 20(6):572–584CrossRefPubMed
18.
Zurück zum Zitat Admiraal JM, van Nuenen FM, Burgerhof JGM, Reyners AKL, Hoekstra-Weebers JEHM (2016) Cancer patients' referral wish: effects of distress, problems, socio-demographic and illness-related variables and social support sufficiency. Psychooncology 25(11):1363–1370CrossRefPubMed Admiraal JM, van Nuenen FM, Burgerhof JGM, Reyners AKL, Hoekstra-Weebers JEHM (2016) Cancer patients' referral wish: effects of distress, problems, socio-demographic and illness-related variables and social support sufficiency. Psychooncology 25(11):1363–1370CrossRefPubMed
19.
Zurück zum Zitat Bauwens S, Baillon C, Distelmans W, Theuns P (2014) Systematic screening for distress in oncology practice using the Distress Barometer: the impact on referrals to psychosocial care. Psychooncology 23(7):804–811CrossRefPubMed Bauwens S, Baillon C, Distelmans W, Theuns P (2014) Systematic screening for distress in oncology practice using the Distress Barometer: the impact on referrals to psychosocial care. Psychooncology 23(7):804–811CrossRefPubMed
Metadaten
Titel
Evaluation of the adherence of distress screening with the distress thermometer in cancer patients 4 years after implementation
verfasst von
Anna Götz
A. Kröner
J. Jenewein
R. Spirig
Publikationsdatum
11.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4579-1

Weitere Artikel der Ausgabe 8/2019

Supportive Care in Cancer 8/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.